Dial Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2003.
2003 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Dial Pharmaceuticals Private Limited

Dial Pharmaceuticals Private Limited, a active private limited company, was established on 01 September 2003 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2003PTC042823. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Employing 19 professional, Its leadership includes Sharadchandra Rasiklal Shah (Additional Director), Darshan Sharadchandra Shah (Additional Director), Rannaben Sanjaybhai Sheth (Director). Past directors included Sanjay Jamnadas Sheth, Jayeshkumar Jamnadas Sheth, Jamnadas Sheth Muljibhai. It holds ₹4.75 Cr open charges and ₹16.06 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, 382445.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ2003PTC042823

  • Registration Number

    042823

  • Incorporation Date

    01 September 2003

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 22 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.75 Cr
  • Satisfied Charges ₹ 16.06 Cr
  • Revenue Growth **** -21.05%
  • Profit Growth **** -231.99%
  • Ebitda **** 163.29%
  • Net Worth -74.81%
  • Total Assets -14.67%
Company report

Dial Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dial Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dial Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sharadchandra Rasiklal Shah Additional Director 07 Aug 2025 Current
Darshan Sharadchandra Shah Additional Director 07 Aug 2025 Current
Rannaben Sanjaybhai Sheth Director 01 Sep 2003 Current
Bindiben Jayeshbhai Sheth Director 01 Sep 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Jun 2025 Past
Pramod Abcsdd Director 03 Jan 2024 Past
Pramod Abcsdd Director 02 Aug 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dial Pharmaceuticals.

Dial Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 21.05% decrease. The company also saw a substantial fall in profitability, with a 231.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74.81%.

Dial Pharmaceuticals revenue growth over time
Dial Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -21.05%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.80%
*******
*******
*******
*******
Total Assets
*******
 -14.67%
*******
*******
*******
*******
Profit or Loss
*******
 -231.99%
*******
*******
*******
*******
Net Worth
*******
 -74.81%
*******
*******
*******
*******
EBITDA
*******
 163.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dial Pharmaceuticals?

Unlock access to Dial Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹47,500,000.00

Satisfied Charges

₹160,575,000.00

Charges Breakdown by Lending Institutions
  • Others : 4.75 Cr
Latest Charge Details
Date Lender Amount Status
06 Sep 2025 Others ₹4.75 Cr Open
27 Nov 2020 Others ₹2.90 Cr Satisfied
16 Jun 2020 Sidbi ₹5.00 M Satisfied
17 Dec 2019 Others ₹7.48 Cr Satisfied
17 Jun 2017 Others ₹2.38 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dial Pharmaceuticals?

Dial Pharmaceuticals has a workforce of 19 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dial Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dial Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dial Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dial Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 47.50 M with Charge ID 101151772 was registered on 06 Sep 2025. was completed.

  • Director Appointment

    Sharadchandra Rasiklal Shah was appointed as a Additional Director was appointed as a Additional Director on 07 Aug 2025 & has been associated with this company since 6 months 7 days . was recorded as a recent event.

  • Director Appointment

    Darshan Sharadchandra Shah was appointed as a Additional Director was appointed as a Additional Director on 07 Aug 2025 & has been associated with this company since 6 months 7 days . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 17 Dec 2019 via Charge ID 100354092 with Others was fully satisfied on 24 Apr 2025. was documented.

  • Balance Sheet

    Progress on Dial Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dial Pharmaceuticals Private Limited?

The CIN of Dial Pharmaceuticals Private Limited is U24231GJ2003PTC042823.

Where is Dial Pharmaceuticals Private Limited headquartered?

Dial Pharmaceuticals Private Limited is headquartered at 3701 / A Phase Ivg I D C Estate Vatva, Ahmedabad, Gujarat, 382445.

When was Dial Pharmaceuticals Private Limited incorporated?

Dial Pharmaceuticals Private Limited was incorporated on 01 September 2003.

Who are the current directors of Dial Pharmaceuticals Private Limited?

The current directors of Dial Pharmaceuticals Private Limited are

What is the primary industry of Dial Pharmaceuticals Private Limited?

The primary industry of Dial Pharmaceuticals Private Limited is Manufacturing.

Is Dial Pharmaceuticals Private Limited a listed company?

Dial Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dial Pharmaceuticals Private Limited?

The authorized capital of Dial Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Dial Pharmaceuticals Private Limited?

The compliance status of Dial Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available